Literature DB >> 22528841

Nocturnal blood pressure, morning blood pressure surge, and cerebrovascular events.

Yuichiro Yano1, Kazuomi Kario.   

Abstract

Cerebrovascular disease is a common cause of death and major cause of disability worldwide. Even in silent cases (e.g., silent cerebral infarction, white matter lesion), cerebrovascular disease can lead to physical and cognitive impairment, thereby substantially reducing the activities of daily living. Accordingly, the earliest possible action to prevent not only symptomatic but also silent cerebrovascular disease has become a major public health challenge. Hypertension is a potent risk factor for both symptomatic and silent cerebrovascular disease. Twenty-four-hour blood pressure (BP) rather than office BP is closely associated with cerebrovascular disease and/or poor physical and cognitive function. In particular, nocturnal BP and morning BP surge have attracted much attention as risk factors for cerebrovascular diseases independently of 24-h BP level. This review is an attempt to summarize some of the evidence on nocturnal BP level or nocturnal BP dipping status, and morning BP surge as potent risk factors for cerebrovascular disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528841     DOI: 10.1007/s11906-012-0261-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  60 in total

1.  Extent of cerebral white matter lesions is related to changes of circadian blood pressure rhythmicity.

Authors:  D Sander; K Winbeck; J Klingelhöfer; B Conrad
Journal:  Arch Neurol       Date:  2000-09

2.  Reproducibility of nocturnal blood pressure assessed by self-measurement of blood pressure at home.

Authors:  Keiko Hosohata; Masahiro Kikuya; Takayoshi Ohkubo; Hirohito Metoki; Kei Asayama; Ryusuke Inoue; Taku Obara; Junichiro Hashimoto; Kazuhito Totsune; Haruhisa Hoshi; Hiroshi Satoh; Yutaka Imai
Journal:  Hypertens Res       Date:  2007-08       Impact factor: 3.872

3.  Association of gait and balance disorders with age-related white matter changes: the LADIS study.

Authors:  H Baezner; C Blahak; A Poggesi; L Pantoni; D Inzitari; H Chabriat; T Erkinjuntti; F Fazekas; J M Ferro; P Langhorne; J O'Brien; P Scheltens; M C Visser; L O Wahlund; G Waldemar; A Wallin; M G Hennerici
Journal:  Neurology       Date:  2008-03-18       Impact factor: 9.910

4.  Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

Authors:  Henry R Black; William J Elliott; Gregory Grandits; Patricia Grambsch; Tracy Lucente; William B White; James D Neaton; Richard H Grimm; Lennart Hansson; Yves Lacourciere; James Muller; Peter Sleight; Michael A Weber; Gordon Williams; Janet Wittes; Alberto Zanchetti; Robert J Anders
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

5.  Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity.

Authors:  Raffaele Marfella; Mario Siniscalchi; Michele Portoghese; Clara Di Filippo; Franca Ferraraccio; Concetta Schiattarella; Basilio Crescenzi; Paolo Sangiuolo; Giuseppe Ferraro; Silvio Siciliano; Francesca Cinone; Gennaro Mazzarella; Simone Martis; Mario Verza; Ludovico Coppola; Francesco Rossi; Michele D'Amico; Giuseppe Paolisso
Journal:  Hypertension       Date:  2007-02-19       Impact factor: 10.190

6.  Morning blood pressure peak, QT intervals, and sympathetic activity in hypertensive patients.

Authors:  Raffaele Marfella; Pasquale Gualdiero; Mario Siniscalchi; Caterina Carusone; Mario Verza; Salvatore Marzano; Katherine Esposito; Dario Giugliano
Journal:  Hypertension       Date:  2003-02       Impact factor: 10.190

7.  Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study.

Authors:  José Boggia; Yan Li; Lutgarde Thijs; Tine W Hansen; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Tatiana Kuznetsova; Christian Torp-Pedersen; Lars Lind; Hans Ibsen; Yutaka Imai; Jiguang Wang; Edgardo Sandoya; Eoin O'Brien; Jan A Staessen
Journal:  Lancet       Date:  2007-10-06       Impact factor: 79.321

8.  Associations of ambulatory blood pressure levels with white matter hyperintensity volumes in hypertensive patients.

Authors:  Léon H Henskens; Abraham A Kroon; Robert J van Oostenbrugge; Ed H Gronenschild; Paul A Hofman; Jan Lodder; Peter W de Leeuw
Journal:  J Hypertens       Date:  2009-07       Impact factor: 4.844

9.  Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort.

Authors:  Domenico Inzitari; Giovanni Pracucci; Anna Poggesi; Giovanna Carlucci; Frederik Barkhof; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; Peter Langhorne; John O'Brien; Philip Scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Leonardo Pantoni
Journal:  BMJ       Date:  2009-07-06

10.  Association between concurrent and remote blood pressure and disability in older adults.

Authors:  Ihab Hajjar; Daniel T Lackland; L Adrienne Cupples; Lewis A Lipsitz
Journal:  Hypertension       Date:  2007-11-19       Impact factor: 10.190

View more
  19 in total

1.  Morning hypertension and night non-dipping in patients with diabetes and chronic kidney disease.

Authors:  Se Won Oh; Sang Youb Han; Kum Hyun Han; Ran-hui Cha; Sejoong Kim; Sun Ae Yoon; Dong-Ryeol Rhu; Jieun Oh; Eun Young Lee; Dong Ki Kim; Yon Su Kim
Journal:  Hypertens Res       Date:  2015-08-27       Impact factor: 3.872

Review 2.  Sleep and pregnancy-induced hypertension: a possible target for intervention?

Authors:  Alyssa Haney; Daniel J Buysse; Michele Okun
Journal:  J Clin Sleep Med       Date:  2013-12-15       Impact factor: 4.062

Review 3.  Secondary Stroke Prevention: Improving Diagnosis and Management with Newer Technologies.

Authors:  Yahia Z Imam; Atlantic D'Souza; Rayaz A Malik; Ashfaq Shuaib
Journal:  Transl Stroke Res       Date:  2016-09-02       Impact factor: 6.829

4.  Comparison of bisoprolol to a metoprolol CR/ZOK tablet for control of heart rate and blood pressure in mild-to-moderate hypertensive patients: the CREATIVE study.

Authors:  Tianlun Yang; Yinong Jiang; Yuming Hao; Shuxian Zhou; Xinjuan Xu; Baiming Qu; Xue Lin; Tianrong Ma
Journal:  Hypertens Res       Date:  2016-08-18       Impact factor: 3.872

5.  Morning blood pressure surge is associated with serum gamma-glutamyltransferase activity in essential hypertensive patients.

Authors:  R Elsurer; B Afsar
Journal:  J Hum Hypertens       Date:  2014-08-28       Impact factor: 3.012

Review 6.  Targeting blood pressure for stroke prevention: current evidence and unanswered questions.

Authors:  Yannick Béjot
Journal:  J Neurol       Date:  2019-06-26       Impact factor: 4.849

7.  Neighborhood problems and nocturnal blood pressure dipping.

Authors:  Frank Euteneuer; Paul J Mills; Meredith A Pung; Winfried Rief; Joel E Dimsdale
Journal:  Health Psychol       Date:  2013-11-18       Impact factor: 4.267

8.  Estimate of nocturnal blood pressure and detection of non-dippers based on clinical or ambulatory monitoring in the inpatient setting.

Authors:  Tan Xu; Yongqing Zhang; Xuerui Tan
Journal:  BMC Cardiovasc Disord       Date:  2013-05-21       Impact factor: 2.298

9.  Morning Blood Pressure Surge as a Predictor of Development of Chronic Kidney Disease.

Authors:  Osman Turak; Baris Afsar; Dimitrie Siriopol; Firat Ozcan; Kumral Cagli; Cagri Yayla; Fatih Oksuz; Mehmet Ali Mendi; Kazuomi Kario; Adrian Covic; Mehmet Kanbay
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-11-04       Impact factor: 3.738

10.  Relationship between elevated morning blood pressure surge, uric acid, and cardiovascular outcomes in hypertensive patients.

Authors:  Osman Turak; Baris Afsar; Firat Ozcan; Ugur Canpolat; Enis Grbovic; Mehmet Ali Mendi; Fatih Oksuz; Dimitrie Siriopol; Adrian Covic; Mustafa Caliskan; Kim McFann; Richard J Johnson; Mehmet Kanbay
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-06-12       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.